Cambridge Trust’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $88.4K | Hold |
3,500
| – | – | ﹤0.01% | 360 |
|
|
2023
Q4 | $81.7K | Hold |
3,500
| – | – | ﹤0.01% | 365 |
|
|
2023
Q3 | $177K | Hold |
3,500
| – | – | 0.01% | 271 |
|
|
2023
Q2 | $163K | Hold |
3,500
| – | – | 0.01% | 290 |
|
|
2023
Q1 | $134K | Hold |
3,500
| – | – | 0.01% | 323 |
|
|
2022
Q4 | $192K | Hold |
3,500
| – | – | 0.01% | 293 |
|
|
2022
Q3 | $119K | Hold |
3,500
| – | – | 0.01% | 338 |
|
|
2022
Q2 | $33K | Hold |
3,500
| – | – | ﹤0.01% | 543 |
|
|
2022
Q1 | $50K | Hold |
3,500
| – | – | ﹤0.01% | 528 |
|
|
2021
Q4 | $74K | Buy |
+3,500
| New | +$74K | ﹤0.01% | 470 |
|